Ready for remote: eCOA and EDC
Whilst a push towards entirely decentralized studies is the end goal nowadays; the industry recognizes the best way forward currently is within a hybrid trial
Whilst a push towards entirely decentralized studies is the end goal nowadays; the industry recognizes the best way forward currently is within a hybrid trial
Want to save time and enhance your clinical trials? Learn how to take your data capture to the next level thanks to our tips and
How to leverage both patient centricity and digital innovation in clinical research? Over the past years, clinical research has entered a new area with an
On December 7th, Andreas Weber, Group CEO at EvidentIQ, sat down with Natalie Yeadon, Co-Founder & CEO at Impetus Digital to discuss hybrid vs. fully decentralized trials,
Looking for a way to digitize the Informed Consent process and facilitate your clinical trials? On November 18th our eConsent webinar took place. We showed
We know that bringing the patient perspective at each step of the medical product life cycle is crucial to ensure the success of a new
EvidentIQ Group GmbH Rathausmarkt 5, 20095 Hamburg, Germany.
Copyright 2024 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us: